latest update:
[TrialBase DB]

trial summary · NCT07621614

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

A Multi-Institutional Central Pathology and Molecular Risk-Based Stratification Study of Surgical Management for Melanoma, Atypical Spitz/Spitzoid Tumors, and Other Atypical Melanocytic Neoplasms in Pediatric Patients

Trial record from the TrialBase DB dataset, status RECRUITING, condition Clinical Stage 0 Cutaneous Melanoma AJCC v8, sponsored by Children's Oncology Group. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07621614phase PHASE2enrollment 51start 2027-05-15

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

This phase II trial compares the effect of using risk-based stratification to guide surgical management to the usual approach in treating cutaneous melanoma, atypical Spitz/Spitzoid tumors or other atypical melanocytic tumors that have not spread to other parts of the body (localized). Melanoma is a cancer that in children is sometimes difficult to tell apart from benign (not harmful) or atypical (uncertain if harmful) skin lesions. Failure to diagnose melanoma can result in inadequate surgical removal and increase the risk of recurrence and metastatic disease (spread from where it first started to other places in the body). In addition, diagnosing a tumor a benign (not cancer) tumor as cancer may lead to unnecessary surgery and treatment. This trial reviews tumor pathology and genetic markers and classifies the tumor as not atypical, atypical but low risk for spread and/or recurrence (coming back after a period of improvement), and atypical and high risk for spread and/or recurrence. The classifications are then used to provide surgical recommendations. Tumors that are not atypical do not receive any surgical treatment. Low-risk recommendations include removing a small layer of normal skin around the tumor. High-risk recommendations include the usual adult melanoma approach of removing a larger layer of normal skin around the tumor with or without a biopsy of the sentinel lymph node (the first lymph node to which tumor cells are likely to spread from a primary tumor). Risk-based guided surgical management may help avoid unnecessary surgery while improving outcomes in …

Source record: https://clinicaltrials.gov/study/NCT07621614

Facts

registry idNCT07621614
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasePHASE2
study typeINTERVENTIONAL
lead conditionClinical Stage 0 Cutaneous Melanoma AJCC v8
sponsorChildren's Oncology Group
sponsor classNETWORK
enrollment51
start date2027-05-15
primary completion2028-07-31
completion2028-07-31
results postednot reported

Conditions

  • Clinical Stage 0 Cutaneous Melanoma AJCC v8
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • Clinical Stage II Cutaneous Melanoma AJCC v8
  • Cutaneous Melanocytic Neoplasm
  • Cutaneous Melanoma
  • Cutaneous Spitz Melanocytoma
  • Cutaneous Spitz Melanoma

Interventions

  • Biospecimen Collection
  • Chest Radiography
  • Computed Tomography
  • Fludeoxyglucose F-18
  • Magnetic Resonance Imaging
  • Patient Observation
  • Positron Emission Tomography
  • Re-Excision
  • Sentinel Lymph Node Biopsy
  • Ultrasound Imaging
  • Wide Local Excision

Countries

  • United States

Intervention types: OTHER, PROCEDURE

Work with this record